Drugs / Dengue Vaccine Formulation 17
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00384670 | Aug 2003 → May 2004 | dengue disease | U.S. Army Medical Research and Development Command | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dengue Vaccine Formulation 17 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00384670 ↗ |
| Modality | Vaccine | “Tetravalent live attenuated DEN vaccine candidate.” NCT00384670 ↗ |
| Route | Subcutaneous | “1 mL subcutaneous injection Dengue Vaccine Formulation 17” NCT00384670 ↗ |